Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stephan Herbertz"'
Autor:
Luis Paz-Ares, Irene Ferrer, Gerald Schmid-Bindert, Stephan Herbertz, William J. John, Jon Zugazagoitia
Publikováno v:
Lung Cancer. 124:53-64
In patients with non-small cell lung cancer (NSCLC), the most frequent oncogene driver mutation in Western countries is Kirsten rat sarcoma viral oncogene homolog (KRAS), and KRAS-mutant NSCLC is associated with smoking. There are various sources of
Autor:
Martin Schuler, Boyka Markova, Stefan Kasper, Stephan Herbertz, Frank Breitenbuecher, Patricia S. Hähnel
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 138:545-554
Pemetrexed, an inhibitor of thymidylate synthase (TS) and additional folate-dependent enzymes, is clinically active in patients suffering from “non-squamous” non-small cell lung cancer (NSCLC). High expression of TS has been implied as biomarker
Autor:
Jan Mollenhauer, Stephan Herbertz, Annemarie Poustka, Liane Schmitt, Uffe Holmskov, Stefan Lyer, Laura Diedrichs, Floris J. Bikker, Toon Ligtenberg, Hanna Müller, Inge Krebs, Herwart F. Otto, Jens Madsen, Stefan Wiemann, Gaby Kollender, Burkhard Helmke
Publikováno v:
Genes, Chromosomes and Cancer. 35:164-169
Deleted in Malignant Brain Tumors 1 (DMBT1) at chromosome region 10q25.3-q26.1 has been proposed as a candidate tumor-suppressor gene for brain, digestive tract, and lung cancer. Recent studies on its expression in lung cancer have led to divergent r
Autor:
Ann Cleverly, Christopher A. Slapak, Susan C. Guba, Karim A. Benhadji, J. Scott Sawyer, Anja Stauber, Kyla Driscoll, Michael Lahn, Stephan Herbertz, Ivelina Gueorguieva, Durisala Desaiah, Shawn T. Estrem
Publikováno v:
Drug Design, Development and Therapy
Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks of cancer, including tumor proliferation, invasion and metastasis, inf
Autor:
Jan, Mollenhauer, Hanna, Müller, Gaby, Kollender, Stefan, Lyer, Laura, Diedrichs, Burkhard, Helmke, Uffe, Holmskov, Toon, Ligtenberg, Stephan, Herbertz, Inge, Krebs, Jens, Madsen, Floris, Bikker, Liane, Schmitt, Stefan, Wiemann, Wolfram, Scheurlen, Herwart F, Otto, Andreas, von Deimling, Annemarie, Poustka
Publikováno v:
Genes, chromosomescancer. 35(3)
Deleted in malignant brain tumors 1 (DMBT1) at 10q25.3-q26.1 has been proposed as a candidate tumor-suppressor gene for brain and epithelial cancer. DMBT1 encodes a multifunctional mucin-like protein presumably involved in epithelial differentiation
Autor:
Uffe Holmskov, Annemarie Poustka, Johannes F. Coy, Stephan Herbertz, Inge Krebs, Petra Kioschis, Jan Mollenhauer, Stefan Wiemann, Jens Madsen
Publikováno v:
Mollenhauer, J, Holmskov, U, Wiemann, S, Krebs, I, Herbertz, S, Madsen, J, Kioschis, P, Coy, J F & Poustka, A 1999, ' The genomic structure of the DMBT1 gene : Evidence for a region with susceptibility to genomic instability ', Oncogene, vol. 18, no. 46, pp. 6233-40 . https://doi.org/10.1038/sj.onc.1203071
Udgivelsesdato: 1999-Nov-4 Increasing evidence has accumulated for an involvement of the inactivation of tumour suppressor genes at chromosome 10q in the carcinogenesis of brain tumours, melanomas, and carcinomas of the lung, the prostate, the pancre
Publikováno v:
Pharmacoepidemiology & Drug Safety; Oct2023 Supplement 1, Vol. 32, p3-612, 610p
Autor:
Herbertz, Stephan, Sawyer, J. Scott, Stauber, Anja J., Gueorguieva, Ivelina, Driscol, Kyla E., Estrem, Shawn T., Cleverly, Ann L., Desaiah, Durisala, Guba, Susan C., Benhadji, Karim A., Slapak, Christopher A., Lahn, Michael M.
Publikováno v:
Drug Design, Development & Therapy; 2015, Vol. 9, p4479-4499, 21p
Autor:
Markova, Boyka, Hähnel, Patricia, Kasper, Stefan, Herbertz, Stephan, Schuler, Martin, Breitenbuecher, Frank
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Apr2012, Vol. 138 Issue 4, p545-554, 10p